These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7306187)

  • 1. cis-Aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate.
    Shen WC; Ryser HJ
    Biochem Biophys Res Commun; 1981 Oct; 102(3):1048-54. PubMed ID: 7306187
    [No Abstract]   [Full Text] [Related]  

  • 2. Isomer-dependent daunomycin release and in vitro antitumour effect of cis-aconityl-daunomycin.
    Reményi J; Balázs B; Tóth S; Falus A; Tóth G; Hudecz F
    Biochem Biophys Res Commun; 2003 Apr; 303(2):556-61. PubMed ID: 12659854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of antibody responses in rats to murine monoclonal antibody 791T/36 by treatment with daunomycin-cis-aconityl-791T/36 conjugates.
    Durrant LG; Robins RA; Marksman RA; Garnett MC; Ogunmuyiwa Y; Baldwin RW
    Cancer Immunol Immunother; 1989; 28(1):37-42. PubMed ID: 2783300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte membrane-bound daunorubicin as a delivery system in anticancer treatment.
    Gaudreault RC; Bellemare B; Lacroix J
    Anticancer Res; 1989; 9(4):1201-5. PubMed ID: 2817803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mode of interaction of 4'-epi-adriamycin and 4-demethoxy-daunomycin with DNA.
    Plumbridge TW; Brown JR
    Biochem Pharmacol; 1978; 27(14):1881-2. PubMed ID: 708470
    [No Abstract]   [Full Text] [Related]  

  • 6. The reaction of polylysine with 2,4-dinitrofluorobenzene.
    Parker RC; Rakowitz R; Kristol DS
    Int J Biochem; 1978; 9(2):117-9. PubMed ID: 25206
    [No Abstract]   [Full Text] [Related]  

  • 7. Nucleic acid binding drugs. Some conformational properties of the anti-cancer drug daunomycin and several of its derivatives: implications for DNA-binding.
    Neidle S; Taylor GL
    FEBS Lett; 1979 Nov; 107(2):348-54. PubMed ID: 510544
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of the structure of branched polypeptide carrier on intracellular delivery of daunomycin.
    Reményi J; Csík G; Kovács P; Reig F; Hudecz F
    Biochim Biophys Acta; 2006 Mar; 1758(3):280-9. PubMed ID: 16500616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of charge on the rate of amide proton exchange.
    Kim PS; Baldwin RL
    Biochemistry; 1982 Jan; 21(1):1-5. PubMed ID: 6174148
    [No Abstract]   [Full Text] [Related]  

  • 10. An NMR study of the interaction of daunomycin with dinucleotides and dinucleoside phosphates.
    Nuss ME; James TL; Apple MA; Kollman PA
    Biochim Biophys Acta; 1980 Aug; 609(1):136-47. PubMed ID: 7407180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.
    Trouet A; Masquelier M; Baurain R; Deprez-De Campeneere D
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):626-9. PubMed ID: 6952214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor reactive cis-aconitylated monoclonal antibodies coupled to daunorubicin through a peptide spacer are unable to kill tumor cells.
    Law KL; Studtmann KE; Carlson RE; Swanson TA; Buirge AW; Ahmad A
    Anticancer Res; 1990; 10(3):845-52. PubMed ID: 2369098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic anthracyclines: regiospecific total synthesis of a D-ring indole analogue of daunomycin.
    Kita Y; Kirihara M; Sasho M; Fujii Y; Sekihachi J; Okunaka R; Tamura Y; Shimooka K
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):585-9. PubMed ID: 2347007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of actinomycin D, ethidium, quinacrine, daunorubicin, and tetralysine with DNA: 31P NMR chemical shift and relaxation investigation.
    Wilson WD; Jones RL
    Nucleic Acids Res; 1982 Feb; 10(4):1399-410. PubMed ID: 7071016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p-Benzylthiocarbamoyl-aspartyl-daunorubicin-substituted polytrisacryl. A new drug acid-labile arm-carrier conjugate.
    Daussin F; Boschetti E; Delmotte F; Monsigny M
    Eur J Biochem; 1988 Oct; 176(3):625-8. PubMed ID: 3169016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.
    Ouar Z; Bens M; Vignes C; Paulais M; Pringel C; Fleury J; Cluzeaud F; Lacave R; Vandewalle A
    Biochem J; 2003 Feb; 370(Pt 1):185-93. PubMed ID: 12435274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
    Duncan R; Kopecková-Rejmanová P; Strohalm J; Hume I; Cable HC; Pohl J; Lloyd JB; Kopecek J
    Br J Cancer; 1987 Feb; 55(2):165-74. PubMed ID: 3468994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative studies on the cleavage of collagen with cyanogen bromide].
    Nordwig A; Bandlow W
    Hoppe Seylers Z Physiol Chem; 1968 Feb; 349(2):148-52. PubMed ID: 5677001
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of riboflavin-5'-phosphate with poly-(alpha-L-lysine) & poly-(alpha-L-histidine) in aqueous medium.
    Srivastava GP; Singh C; Ramesh V; Singh S
    Indian J Biochem Biophys; 1981 Jun; 18(3):233-5. PubMed ID: 7309103
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the direct neutral penicilloylation of functional groups occurring on proteins.
    Schneider CH; de Weck AL
    Biochim Biophys Acta; 1968 Sep; 168(1):27-35. PubMed ID: 5684626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.